CO5070625A1 - Procedimiento para elaborar ureas 1,3-disustituidas-4- oxaciclicas - Google Patents

Procedimiento para elaborar ureas 1,3-disustituidas-4- oxaciclicas

Info

Publication number
CO5070625A1
CO5070625A1 CO99025954A CO99025954A CO5070625A1 CO 5070625 A1 CO5070625 A1 CO 5070625A1 CO 99025954 A CO99025954 A CO 99025954A CO 99025954 A CO99025954 A CO 99025954A CO 5070625 A1 CO5070625 A1 CO 5070625A1
Authority
CO
Colombia
Prior art keywords
imidazolidinedione
furanyl
disubstituted
piperazinyl
chlorophenyl
Prior art date
Application number
CO99025954A
Other languages
English (en)
Inventor
Patricia Ann Matson
Michael Selden Goldlewski
Daniel Quorroz
Guggisberg Yves
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of CO5070625A1 publication Critical patent/CO5070625A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se relaciona con un procedimiento para elaboración de dihidrocloruro de 1-[[[5-(4-Clorofenilo)-2-furanilo]metileno]amino]-3-[4(4-metil-1-piperazinilo )butilo]-2,4-imidazolidinadiona que comprende los pasos de: (Ia) reaccionar1-[[[5-(4-clorofenilo)-2-furanilo]metileno ]amino]-3-[4(4-metil-1-piperazinilo)butilo]-2,4-imidazolidinadiona con un reagente de cadena de carbonos que tienen dos grupos salientes en presencia de una base suave y N-metilpirrolidona para formar un aducto que contiene un grupo saliente; y (lb) condensar el aducto con N-metilpiperazina para formar una urea 1,3-disustituida-4-oxocíclica; y (II) recuperar dicha urea 1,3-disustituida-4-oxocíclica por medio de los siguientes pasos: (lla) adición de un cosolvente tal como metanol, etanol, acetona y mezcla de ellos; (Ilb) filtración de las sales precipitadas, adición de agua; (Ilc) ajuste de pH con ácido hidroclórico primero ajustando el pH a 4.5 a 5, seguido por ajuste a pH O a 3; y (lld) filtración del producto.
CO99025954A 1998-04-29 1999-04-29 Procedimiento para elaborar ureas 1,3-disustituidas-4- oxaciclicas CO5070625A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8349398P 1998-04-29 1998-04-29

Publications (1)

Publication Number Publication Date
CO5070625A1 true CO5070625A1 (es) 2001-08-28

Family

ID=22178700

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99025954A CO5070625A1 (es) 1998-04-29 1999-04-29 Procedimiento para elaborar ureas 1,3-disustituidas-4- oxaciclicas

Country Status (28)

Country Link
US (1) US6414151B1 (es)
EP (1) EP1075473B1 (es)
JP (1) JP4549531B2 (es)
KR (1) KR100400050B1 (es)
CN (1) CN1298403A (es)
AR (1) AR015044A1 (es)
AT (1) ATE366251T1 (es)
AU (1) AU751681B2 (es)
BR (1) BR9910074A (es)
CA (1) CA2330686C (es)
CO (1) CO5070625A1 (es)
CZ (1) CZ299163B6 (es)
DE (1) DE69936449T2 (es)
DK (1) DK1075473T3 (es)
ES (1) ES2288020T3 (es)
HU (1) HUP0102666A3 (es)
ID (1) ID27452A (es)
IL (1) IL138404A (es)
MY (1) MY133753A (es)
NO (1) NO20005424D0 (es)
PE (1) PE20000925A1 (es)
PL (1) PL197776B1 (es)
RU (1) RU2194706C2 (es)
SG (1) SG120901A1 (es)
SK (1) SK15842000A3 (es)
TR (1) TR200003137T2 (es)
WO (1) WO1999055700A1 (es)
ZA (1) ZA200004712B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420568B1 (en) * 1998-04-29 2002-07-16 The Procter & Gamble Company Process for making 1,3-disubstituted-4-oxocyclic ureas
CN100443473C (zh) * 2005-04-30 2008-12-17 中国药科大学 1-氨基-3-(氮杂环基烷基)-2,4-咪唑二酮的合成方法
TW200840578A (en) * 2006-12-15 2008-10-16 Procter & Gamble Compositions of azimilide dihydrochloride
US20120178762A1 (en) 2006-12-15 2012-07-12 Warner Chilcott Company, Llc Compositions of azimilide dihydrochloride
CN101735205B (zh) * 2009-12-17 2013-05-15 天津药物研究院 盐酸阿齐利特的晶型ⅴ及其制备方法和用途
CN101735202B (zh) * 2009-12-17 2012-05-30 天津药物研究院 盐酸阿齐利特的晶型ⅰ及其制备方法和用途
CN101735203B (zh) * 2009-12-17 2012-05-23 天津药物研究院 盐酸阿齐利特的晶型ⅱ及其制备方法和用途
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906010A (en) 1974-06-17 1975-09-16 Morton Norwich Products Inc Series of 5-aryl-2-furamidines
US3919231A (en) 1974-06-17 1975-11-11 Morton Norwich Products Inc Series of 5-aryl-2-furamidines
US3946049A (en) 1975-04-03 1976-03-23 Morton-Norwich Products, Inc. 5-phenyl-2-furamidoximes
US4001222A (en) 1975-10-14 1977-01-04 Morton-Norwich Products, Inc. 3-(Aminoacyl)-1-{[5-(substituted phenyl)furfurylidene]amino}hydantoins and process for their preparation thereof
JPS5726653A (en) 1980-05-09 1982-02-12 Ciba Geigy Ag Substituted phenyl ether
IL82856A0 (en) 1986-06-26 1987-12-20 Norwich Eaton Pharma Pharmaceutical compositions containing 2-(5-phenyl-2-furanyl)imidazoles and certain such novel compounds
US4882354A (en) 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
US5019651A (en) 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
JP3031973B2 (ja) * 1990-08-16 2000-04-10 富士レビオ株式会社 フェニトイン誘導体
CA2115029C (en) 1991-08-14 2002-03-26 Stanford Salvatore Pelosi, Jr. Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents
EP1231208A3 (en) * 1991-08-14 2003-12-10 Procter & Gamble Pharmaceuticals 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents
US6420568B1 (en) * 1998-04-29 2002-07-16 The Procter & Gamble Company Process for making 1,3-disubstituted-4-oxocyclic ureas

Also Published As

Publication number Publication date
ZA200004712B (en) 2003-02-26
DE69936449D1 (de) 2007-08-16
EP1075473B1 (en) 2007-07-04
DK1075473T3 (da) 2007-11-05
RU2194706C2 (ru) 2002-12-20
IL138404A (en) 2004-07-25
HUP0102666A2 (hu) 2002-03-28
NO20005424L (no) 2000-10-27
CZ299163B6 (cs) 2008-05-07
PL343734A1 (en) 2001-09-10
IL138404A0 (en) 2001-10-31
HUP0102666A3 (en) 2002-05-28
JP2002513021A (ja) 2002-05-08
AU3573599A (en) 1999-11-16
NO20005424D0 (no) 2000-10-27
JP4549531B2 (ja) 2010-09-22
CA2330686C (en) 2006-09-26
BR9910074A (pt) 2000-12-26
CA2330686A1 (en) 1999-11-04
TR200003137T2 (tr) 2001-02-21
US6414151B1 (en) 2002-07-02
EP1075473A1 (en) 2001-02-14
WO1999055700A1 (en) 1999-11-04
KR20010043052A (ko) 2001-05-25
ES2288020T3 (es) 2007-12-16
SK15842000A3 (sk) 2001-06-11
PL197776B1 (pl) 2008-04-30
ATE366251T1 (de) 2007-07-15
ID27452A (id) 2001-04-12
PE20000925A1 (es) 2000-11-17
KR100400050B1 (ko) 2003-09-29
DE69936449T2 (de) 2008-03-06
AU751681B2 (en) 2002-08-22
CN1298403A (zh) 2001-06-06
CZ20003951A3 (cs) 2001-08-15
SG120901A1 (en) 2006-04-26
AR015044A1 (es) 2001-04-11
MY133753A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
NL350075I2 (es)
DK1206467T3 (da) N-heterocykliske derivater som NOS-inhibitorer
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DE69627035D1 (de) Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren
ATE503827T1 (de) Optische aufheller, deren herstellung und verwendung
BRPI0418149A (pt) derivados heterocìclicos como agonistas do receptor de gprc
TR200101744T2 (tr) Fenilglisin türevleri.
DK0968206T3 (da) N-heterocykliske derivater som NOS-inhibitorer
BRPI0410760A (pt) compostos, processo para fabricação dos mesmos, composições farmacêuticas e uso deste compostos
IL168718A (en) Biguanide derivatives, compositions comprising the derivatives, process for preparing an antimicrobial compound and use of the derivatives in the preparation of medicaments
SE9904108D0 (sv) Nya föreningar
NO20054787D0 (no) Indenderivater som farmasotiske midler
BR0007589A (pt) Inibidores da proliferação de células
BR0312563A (pt) Comprimido de lasofoxifeno e seu revestimento
DE602004005323D1 (de) Azidfreies verfahren zur herstellung von 1,2-diaminoverbindungen
ATE416157T1 (de) Inhibitoren von integrin alpha-v-beta-6
BR0315801A (pt) Compostos piridopirimidinona, eu processo de preparação e as composições farmacêuticas que os contêm
CO5070625A1 (es) Procedimiento para elaborar ureas 1,3-disustituidas-4- oxaciclicas
EP0903347A4 (es)
ATE345349T1 (de) Purinderivate
DE60001182D1 (de) Erythromycin-Derivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel
EA200600046A1 (ru) Производные 6-[2-(фосфонометокси)алкокси]пиримидинов (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции
WO2003066594A3 (de) 3-alkanoylamino-propionsäure-derivate als inhibitoren des integrins avss6
BRPI0411308A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto